Table 1.
Clinical characteristics of men enrolled in the present study. PCa: prostate cancer; PSA: prostate-specific antigen; ISUP: International Society of Urological Pathology; SD: standard deviation; nd: not defined.
| Characteristics | PCa Group | Non-PCa Group | p-Value | |
|---|---|---|---|---|
| Subjects | 15 | 15 | nd | |
| Age, years: mean (SD) | 68 (9) | 69 (8) | 0.621 | |
| PSA, ng/mL: median (range) | 9 (3–28) | 9 (3–32) | 0.640 | |
| Prostate volume, g: mean (range) | 37 (56) | 79 (230) | 0.015 | |
| Charlson index: n (%) | 1 | 2 (13%) | 2 (13%) | 0.799 |
| 2 | 4 (27%) | 2 (13%) | ||
| 3 | 4 (27%) | 5 (33%) | ||
| 4 | 1 (7%) | 3 (20%) | ||
| 5 | 2 (13%) | 2 (13%) | ||
| 6 | 1 (7%) | 1 (7%) | ||
| 7 | 1 (7%) | 0 | ||
| ISUP grade: n (%) | 1 | 3 (20%) | nd | nd |
| 2 | 6 (40%) | nd | ||
| 3 | 2 (13%) | nd | ||
| 4 | 2 (13%) | nd | ||
| 5 | 2 (13%) | nd | ||